Patent details

EP3057990 Title: COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY

Basic Information

Publication number:
EP3057990
PCT Application Number:
US2014061071
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147926869
PCT Publication Number:
WO2015058048
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY
French Title of Invention:
COMPOSITIONS COMPRENANT UNE COMBINAISON D'ANTAGONISTE DU VEGF ET D'ANTICORPS ANTI-CTLA-4
German Title of Invention:
ZUSAMMENSETZUNGEN MIT EINER KOMBINATION AUS EINEM VEGF-ANTAGONISTEN UND EINEM ANTI-CTLA-4-ANTIKÖRPER
SPC Number:

Dates

Filing date:
17/10/2014
Grant date:
04/09/2019
EP Publication Date:
24/08/2016
PCT Publication Date:
23/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2019
EP B1 Publication Date:
04/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/10/2019
Expiration date:
17/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/08/2019
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:
BUROVA, Elena
Address:
United States (US)

2

Name:
IOFFE, Ella
Address:
United States (US)

3

Name:
LOWY, Israel
Address:
United States (US)

4

Name:
THURSTON, Gavin
Address:
United States (US)

Priority

1

Priority Number:
201361892601 P
Priority Date:
18/10/2013
Priority Country:
United States (US)

2

Priority Number:
201361901596 P
Priority Date:
08/11/2013
Priority Country:
United States (US)

3

Priority Number:
201461952923 P
Priority Date:
14/03/2014
Priority Country:
United States (US)

4

Priority Number:
201462055734 P
Priority Date:
26/09/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/17; A61K 39/00; A61K 39/395; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
201936
Publication date:
04/09/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages